RIOX2 and cutaneous melanoma: In addition, JMJD10 mRNA expression was significantly lower compared to normal patients in breast invasive carcinoma, kidney renal clear cell carcinoma and kidney renal papillary cell carcinoma, skin cutaneous melanoma, thyroid carcinoma, and uterine corpus endometrial carcinoma.